Which statement describes the purpose of the FDA's Bad Ad Program?

Which statement describes the purpose of the FDA's Bad Ad Program?

• A. It collects reports of potentially false or misleading promotion submitted by healthcare professionals.
• B. It funds promotional campaigns.
• C. It certifies drug manufacturing facilities.
• D. It regulates prescribing guidelines.

Answer: (A)

The question tests understanding that the Bad Ad Program is a channel for healthcare professionals to report potentially false or misleading promotion of prescription drugs to the FDA. Its purpose is to help ensure promotional materials are truthful and not deceptive, so patient safety isn’t compromised. The program relies on healthcare professionals to flag ads, brochures, websites, or other promotional content that seems misleading, and FDA reviews these reports to determine if action is needed. This isn’t about funding promotional campaigns, certifying drug manufacturing facilities, or setting or regulating prescribing guidelines. Those activities lie outside the Bad Ad Program’s scope; instead, the emphasis is on identifying and addressing misleading promotion to protect patients.

The question tests understanding that the Bad Ad Program is a channel for healthcare professionals to report potentially false or misleading promotion of prescription drugs to the FDA. Its purpose is to help ensure promotional materials are truthful and not deceptive, so patient safety isn’t compromised. The program relies on healthcare professionals to flag ads, brochures, websites, or other promotional content that seems misleading, and FDA reviews these reports to determine if action is needed.

This isn’t about funding promotional campaigns, certifying drug manufacturing facilities, or setting or regulating prescribing guidelines. Those activities lie outside the Bad Ad Program’s scope; instead, the emphasis is on identifying and addressing misleading promotion to protect patients.